|
|
Article: New Paper Published in "Stem Cells" Reporting In-Vivo Migration Ability of Brainstorm Cell Therapeutics' NTF Cells.
- Article from:
- Business Wire
- Article date:
- July 22, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
NEW YORK & PETACH TIKVAH, Israel -- BrainStorm Cell Therapeutics Inc. (OTCBB:BCLI), a leading developer of adult stem cell technologies and therapeutics, is pleased to announce that the company's new therapeutic approach for treating neurodegenerative disease was highlighted in a recent scientific paper that was published in "Stem Cells" highlighting the company's patent technology for treating neurodegenerative diseases. "Stem Cells" is the most well known journal recording findings in the stem cell field. The paper was authored by Tel Aviv University scientists.
The paper, reporting the recent work of Laboratory of Neurosciences, FMRC, Department of Neurology, ...